1	A	a	DT	DT	_	3	det	_	_
2	large	large	JJ	JJ	_	3	amod	_	_
3	outbreak	outbreak	NN	NN	_	0	ROOT	_	_
4	of	of	IN	IN	_	3	prep	_	_
5	Salmonella	salmonella	FW	FW	_	8	nn	_	_
6	Paratyphi	paratyphi	FW	FW	_	8	nn	_	_
7	A	a	DT	DT	_	8	det	_	_
8	infection	infection	NN	NN	_	4	pobj	_	_
9	among	among	IN	IN	_	8	prep	_	_
10	israeli	israeli	JJ	JJ	_	11	amod	_	_
11	travelers	traveler	NNS	NNS	_	9	pobj	_	_
12	to	to	TO	TO	_	11	prep	_	_
13	Nepal	Nepal	NNP	NNP	_	12	pobj	_	_
14	.	.	.	.	_	3	punct	_	_

1	In	in	IN	IN	_	10	prep	_	_
2	Asia	Asia	NNP	NNP	_	1	pobj	_	_
3	,	,	,	,	_	10	punct	_	_
4	Salmonella	salmonella	FW	FW	_	6	nn	_	_
5	Paratyphi	paratyphi	FW	FW	_	6	nn	_	_
6	A	a	NN	NN	_	10	nsubj	_	_
7	is	be	VBZ	VBZ	_	10	cop	_	_
8	an	a	DT	DT	_	10	det	_	_
9	emerging	emerge	VBG	VBG	_	10	amod	_	_
10	infection	infection	NN	NN	_	0	ROOT	_	_
11	,	,	,	,	_	10	punct	_	_
12	and	and	CC	CC	_	10	cc	_	_
13	travelers	traveler	NNS	NNS	_	10	conj	_	_
14	are	be	VBP	VBP	_	13	dep	_	_
15	increasingly	increasingly	RB	RB	_	16	advmod	_	_
16	at	at	IN	IN	_	14	prep	_	_
17	risk	risk	NN	NN	_	16	pobj	_	_
18	.	.	.	.	_	10	punct	_	_

1	During	during	IN	IN	_	14	prep	_	_
2	October	October	NNP	NNP	_	1	pobj	_	_
3	2009-November	2009-november	JJ	JJ	_	4	amod	_	_
4	2009	2009	CD	CD	_	2	num	_	_
5	,	,	,	,	_	14	punct	_	_
6	an	a	DT	DT	_	7	det	_	_
7	outbreak	outbreak	NN	NN	_	14	nsubjpass	_	_
8	in	in	IN	IN	_	7	prep	_	_
9	S.	S.	NNP	NNP	_	12	nn	_	_
10	Paratyphi	Paratyphi	NNP	NNP	_	12	nn	_	_
11	A	A	NNP	NNP	_	12	nn	_	_
12	infection	infection	NN	NN	_	8	pobj	_	_
13	was	be	VBD	VBD	_	14	auxpass	_	_
14	noted	note	VBN	VBN	_	0	ROOT	_	_
15	in	in	IN	IN	_	14	prep	_	_
16	Israeli	israeli	JJ	JJ	_	17	amod	_	_
17	travelers	traveler	NNS	NNS	_	15	pobj	_	_
18	returning	return	VBG	VBG	_	17	vmod	_	_
19	from	from	IN	IN	_	18	prep	_	_
20	Nepal	Nepal	NNP	NNP	_	19	pobj	_	_
21	.	.	.	.	_	14	punct	_	_

1	An	a	DT	DT	_	3	det	_	_
2	outbreak	outbreak	NN	NN	_	3	nn	_	_
3	investigation	investigation	NN	NN	_	4	nsubj	_	_
4	included	include	VBD	VBD	_	0	ROOT	_	_
5	a	a	DT	DT	_	8	det	_	_
6	standardized	standardized	JJ	JJ	_	8	amod	_	_
7	exposure	exposure	NN	NN	_	8	nn	_	_
8	questionnaire	questionnaire	NN	NN	_	4	dobj	_	_
9	admitted	admit	VBD	VBD	_	8	vmod	_	_
10	to	to	TO	TO	_	9	prep	_	_
11	all	all	DT	DT	_	12	det	_	_
12	patients	patient	NNS	NNS	_	10	pobj	_	_
13	and	and	CC	CC	_	12	cc	_	_
14	medical	medical	JJ	JJ	_	16	amod	_	_
15	chart	chart	NN	NN	_	16	nn	_	_
16	abstraction	abstraction	NN	NN	_	12	conj	_	_
17	.	.	.	.	_	4	punct	_	_

1	Isolates	isolate	NNS	NNS	_	3	nsubjpass	_	_
2	were	be	VBD	VBD	_	3	auxpass	_	_
3	tested	test	VBN	VBN	_	0	ROOT	_	_
4	for	for	IN	IN	_	3	prep	_	_
5	antimicrobial	antimicrobial	JJ	JJ	_	6	amod	_	_
6	susceptibility	susceptibility	NN	NN	_	4	pobj	_	_
7	and	and	CC	CC	_	6	cc	_	_
8	pulsed-field	pulsed-field	JJ	JJ	_	10	amod	_	_
9	gel	gel	NN	NN	_	10	nn	_	_
10	electrophoresis	electrophoresis	NN	NN	_	6	conj	_	_
11	-LRB-	-lrb-	-LRB-	-LRB-	_	12	punct	_	_
12	PFGE	pfge	NN	NN	_	10	appos	_	_
13	-RRB-	-rrb-	-RRB-	-RRB-	_	12	punct	_	_
14	.	.	.	.	_	3	punct	_	_

1	During	during	IN	IN	_	15	prep	_	_
2	1	1	CD	CD	_	8	number	_	_
3	October	October	NNP	NNP	_	8	dep	_	_
4	2009-30	2009-30	CD	CD	_	5	num	_	_
5	November	November	NNP	NNP	_	3	dep	_	_
6	2009	2009	CD	CD	_	5	num	_	_
7	,	,	,	,	_	3	punct	_	_
8	37	37	CD	CD	_	10	num	_	_
9	Israeli	israeli	JJ	JJ	_	10	amod	_	_
10	travelers	traveler	NNS	NNS	_	1	pobj	_	_
11	returning	return	VBG	VBG	_	10	vmod	_	_
12	from	from	IN	IN	_	11	prep	_	_
13	Nepal	Nepal	NNP	NNP	_	12	pobj	_	_
14	were	be	VBD	VBD	_	15	auxpass	_	_
15	diagnosed	diagnose	VBN	VBN	_	0	ROOT	_	_
16	with	with	IN	IN	_	15	prep	_	_
17	S.	S.	NNP	NNP	_	20	nn	_	_
18	Paratyphi	Paratyphi	NNP	NNP	_	20	nn	_	_
19	A	A	NNP	NNP	_	20	nn	_	_
20	bacteremia	bacteremia	NN	NN	_	16	pobj	_	_
21	.	.	.	.	_	15	punct	_	_

1	All	all	DT	DT	_	4	det	_	_
2	37	37	CD	CD	_	4	num	_	_
3	case	case	NN	NN	_	4	nn	_	_
4	isolates	isolate	NNS	NNS	_	5	nsubj	_	_
5	had	have	VBD	VBD	_	0	ROOT	_	_
6	an	a	DT	DT	_	8	det	_	_
7	identical	identical	JJ	JJ	_	8	amod	_	_
8	pattern	pattern	NN	NN	_	5	dobj	_	_
9	on	on	IN	IN	_	8	prep	_	_
10	PFGE	pfge	NN	NN	_	9	pobj	_	_
11	,	,	,	,	_	5	punct	_	_
12	and	and	CC	CC	_	5	cc	_	_
13	all	all	DT	DT	_	17	nsubj	_	_
14	were	be	VBD	VBD	_	17	cop	_	_
15	nalidixic	nalidixic	JJ	JJ	_	17	amod	_	_
16	acid	acid	NN	NN	_	17	npadvmod	_	_
17	resistant	resistant	JJ	JJ	_	5	conj	_	_
18	.	.	.	.	_	5	punct	_	_

1	Only	only	RB	RB	_	2	quantmod	_	_
2	1	1	CD	CD	_	4	num	_	_
3	food	food	NN	NN	_	4	nn	_	_
4	venue	venue	NN	NN	_	6	nsubjpass	_	_
5	was	be	VBD	VBD	_	6	auxpass	_	_
6	frequented	frequent	VBN	VBN	_	0	ROOT	_	_
7	by	by	IN	IN	_	6	prep	_	_
8	all	all	PDT	PDT	_	11	predet	_	_
9	the	the	DT	DT	_	11	det	_	_
10	outbreak	outbreak	NN	NN	_	11	nn	_	_
11	cases	case	NNS	NNS	_	7	pobj	_	_
12	,	,	,	,	_	6	punct	_	_
13	with	with	IN	IN	_	6	prep	_	_
14	the	the	DT	DT	_	16	det	_	_
15	largest	largest	JJS	JJS	_	16	amod	_	_
16	number	number	NN	NN	_	13	pobj	_	_
17	of	of	IN	IN	_	16	prep	_	_
18	exposures	exposure	NNS	NNS	_	17	pobj	_	_
19	occurring	occur	VBG	VBG	_	18	vmod	_	_
20	around	around	IN	IN	_	19	prep	_	_
21	the	the	DT	DT	_	24	det	_	_
22	Jewish	jewish	JJ	JJ	_	24	amod	_	_
23	New	New	NNP	NNP	_	24	nn	_	_
24	Year	year	NN	NN	_	20	pobj	_	_
25	.	.	.	.	_	6	punct	_	_

1	All	all	DT	DT	_	2	det	_	_
2	patients	patient	NNS	NNS	_	3	nsubj	_	_
3	recovered	recover	VBD	VBD	_	0	ROOT	_	_
4	without	without	IN	IN	_	3	prep	_	_
5	complications	complication	NNS	NNS	_	4	pobj	_	_
6	.	.	.	.	_	3	punct	_	_

1	Time	Time	NNP	NNP	_	15	nsubj	_	_
2	to	to	TO	TO	_	1	prep	_	_
3	defervescence	defervescence	NN	NN	_	2	pobj	_	_
4	in	in	IN	IN	_	1	prep	_	_
5	17	17	CD	CD	_	6	num	_	_
6	patients	patient	NNS	NNS	_	4	pobj	_	_
7	treated	treat	VBN	VBN	_	6	vmod	_	_
8	with	with	IN	IN	_	7	prep	_	_
9	ceftriaxone	ceftriaxone	NN	NN	_	12	nn	_	_
10	and	and	CC	CC	_	9	cc	_	_
11	azithromycin	azithromycin	NN	NN	_	9	conj	_	_
12	combination	combination	NN	NN	_	8	pobj	_	_
13	was	be	VBD	VBD	_	15	cop	_	_
14	3.2	3.2	CD	CD	_	15	num	_	_
15	days	day	NNS	NNS	_	0	ROOT	_	_
16	-LRB-	-lrb-	-LRB-	-LRB-	_	18	punct	_	_
17	±	±	CD	CD	_	18	num	_	_
18	1.7	1.7	CD	CD	_	15	appos	_	_
19	-RRB-	-rrb-	-RRB-	-RRB-	_	18	punct	_	_
20	,	,	,	,	_	15	punct	_	_
21	whereas	whereas	IN	IN	_	36	mark	_	_
22	in	in	IN	IN	_	36	prep	_	_
23	13	13	CD	CD	_	24	num	_	_
24	cases	case	NNS	NNS	_	22	pobj	_	_
25	treated	treat	VBN	VBN	_	24	vmod	_	_
26	with	with	IN	IN	_	25	prep	_	_
27	ceftriaxone	ceftriaxone	NN	NN	_	28	nn	_	_
28	monotherapy	monotherapy	NN	NN	_	26	pobj	_	_
29	,	,	,	,	_	36	punct	_	_
30	the	the	DT	DT	_	31	det	_	_
31	time	time	NN	NN	_	36	nsubj	_	_
32	to	to	TO	TO	_	31	prep	_	_
33	defervescence	defervescence	NN	NN	_	32	pobj	_	_
34	was	be	VBD	VBD	_	36	cop	_	_
35	6.6	6.6	CD	CD	_	36	num	_	_
36	days	day	NNS	NNS	_	15	advcl	_	_
37	-LRB-	-lrb-	-LRB-	-LRB-	_	39	punct	_	_
38	±	±	CD	CD	_	39	num	_	_
39	1.8	1.8	CD	CD	_	36	dep	_	_
40	;	;	:	:	_	39	punct	_	_
41	P	p	NN	NN	_	39	dep	_	_
42	<	<	JJR	JJR	_	41	amod	_	_
43	.001	.001	CD	CD	_	42	dep	_	_
44	-RRB-	-rrb-	-RRB-	-RRB-	_	39	punct	_	_
45	.	.	.	.	_	15	punct	_	_

1	A	a	DT	DT	_	2	det	_	_
2	point-source	point-source	NN	NN	_	12	nsubjpass	_	_
3	,	,	,	,	_	2	punct	_	_
4	``	``	``	``	_	6	punct	_	_
5	Paratyphoid	Paratyphoid	NNP	NNP	_	6	nn	_	_
6	Mary	Mary	NNP	NNP	_	2	appos	_	_
7	''	''	''	''	_	6	punct	_	_
8	-	-	:	:	_	2	punct	_	_
9	like	like	IN	IN	_	2	prep	_	_
10	outbreak	outbreak	NN	NN	_	9	pobj	_	_
11	was	be	VBD	VBD	_	12	auxpass	_	_
12	identified	identify	VBN	VBN	_	0	ROOT	_	_
13	among	among	IN	IN	_	12	prep	_	_
14	Israeli	israeli	JJ	JJ	_	15	amod	_	_
15	travelers	traveler	NNS	NNS	_	13	pobj	_	_
16	to	to	TO	TO	_	12	prep	_	_
17	Nepal	Nepal	NNP	NNP	_	16	pobj	_	_
18	.	.	.	.	_	12	punct	_	_

1	Combination	combination	NN	NN	_	3	nn	_	_
2	Ceftriaxone-Azithromycin	ceftriaxone-azithromycin	NN	NN	_	3	nn	_	_
3	therapy	therapy	NN	NN	_	5	nsubj	_	_
4	may	may	MD	MD	_	5	aux	_	_
5	provide	provide	VB	VB	_	0	ROOT	_	_
6	a	a	DT	DT	_	8	det	_	_
7	therapeutic	therapeutic	JJ	JJ	_	8	amod	_	_
8	advantage	advantage	NN	NN	_	5	dobj	_	_
9	over	over	IN	IN	_	8	prep	_	_
10	monotherapy	monotherapy	NN	NN	_	9	pobj	_	_
11	,	,	,	,	_	5	punct	_	_
12	and	and	CC	CC	_	5	cc	_	_
13	merits	merit	NNS	NNS	_	16	nn	_	_
14	further	further	RB	RB	_	16	advmod	_	_
15	clinical	clinical	JJ	JJ	_	16	amod	_	_
16	trials	trial	NNS	NNS	_	5	conj	_	_
17	.	.	.	.	_	5	punct	_	_
